1. Home
  2. EVLV vs INBX Comparison

EVLV vs INBX Comparison

Compare EVLV & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$5.76

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$58.86

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
INBX
Founded
2013
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.7M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
EVLV
INBX
Price
$5.76
$58.86
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$9.13
N/A
AVG Volume (30 Days)
3.6M
155.9K
Earning Date
03-10-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
$19.56
N/A
Revenue Next Year
$20.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
550.00
52 Week Low
$2.67
$10.81
52 Week High
$8.90
$94.57

Technical Indicators

Market Signals
Indicator
EVLV
INBX
Relative Strength Index (RSI) 54.65 33.28
Support Level $5.36 $28.54
Resistance Level $5.81 $85.97
Average True Range (ATR) 0.39 4.27
MACD 0.09 -0.55
Stochastic Oscillator 72.33 8.45

Price Performance

Historical Comparison
EVLV
INBX

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: